Assessment of the Electrophysiological Effects of Doxorubicin in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

被引:0
作者
Goineau, S. [1 ]
Hunault, M. [1 ]
Legrand, C. [1 ]
Hayes, E. [1 ]
Froget, G. [1 ]
Castagne, V. [1 ]
机构
[1] Porsolt SAS, Le Genest St Isle, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P517
引用
收藏
页码:95 / 96
页数:2
相关论文
共 50 条
[1]   Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes [J].
Pointon, Amy ;
Harmer, Alexander R. ;
Dale, Ian L. ;
Abi-Gerges, Najah ;
Bowes, Joanne ;
Pollard, Christopher ;
Garside, Helen .
TOXICOLOGICAL SCIENCES, 2015, 144 (02) :227-237
[2]   MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes [J].
Chaudhari, Umesh ;
Nemade, Harshal ;
Gaspar, John Antonydas ;
Hescheler, Jurgen ;
Hengstler, Jan G. ;
Sachinidis, Agapios .
ARCHIVES OF TOXICOLOGY, 2016, 90 (12) :3087-3098
[3]   MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes [J].
Umesh Chaudhari ;
Harshal Nemade ;
John Antonydas Gaspar ;
Jürgen Hescheler ;
Jan G. Hengstler ;
Agapios Sachinidis .
Archives of Toxicology, 2016, 90 :3087-3098
[4]   Electrophysiological maturation of human induced pluripotent stem cell-derived cardiomyocytes [J].
El-Haou, Said ;
Correia, Claudia ;
Christoffersson, Jonas ;
Francis, Jo .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2025, 133
[5]   Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation [J].
Hakli, Martta ;
Kreutzer, Joose ;
Maki, Antti-Juhana ;
Valimaki, Hannu ;
Cherian, Reeja Maria ;
Kallio, Pasi ;
Aalto-Setala, Katriina ;
Pekkanen-Mattila, Mari .
STEM CELLS INTERNATIONAL, 2022, 2022
[6]   Cardiac proarrhythmic risk assessment using human-induced pluripotent stem cell-derived cardiomyocytes [J].
Albert, Verena ;
Jahic, Mirza ;
Servant, Nicole .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
[7]   Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes [J].
Louisse, Jochem ;
Wust, Rob C. I. ;
Pistollato, Francesca ;
Palosaari, Taina ;
Barilari, Manuela ;
Macko, Peter ;
Bremer, Susanne ;
Prieto, Pilar .
TOXICOLOGY IN VITRO, 2017, 42 :182-190
[8]   Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes [J].
A. D. Podgurskaya ;
M. M. Slotvitsky ;
V. A. Tsvelaya ;
S. R. Frolova ;
S. G. Romanova ;
V. A. Balashov ;
K. I. Agladze .
Scientific Reports, 11
[9]   Human-induced pluripotent stem cell-derived cardiomyocytes: phenotypic and functional variability [J].
Koivumaki, J. ;
Nikolay, N. ;
Tuomainen, T. ;
Takalo, J. ;
Tavi, P. .
ACTA PHYSIOLOGICA, 2017, 219 :4-4
[10]   Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes [J].
Podgurskaya, A. D. ;
Slotvitsky, M. M. ;
Tsvelaya, V. A. ;
Frolova, S. R. ;
Romanova, S. G. ;
Balashov, V. A. ;
Agladze, K. I. .
SCIENTIFIC REPORTS, 2021, 11 (01)